| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Yang Yang | |
| Gil Mor | |||
| Gang Yin | |||
| Ilana Chefetz | |||
| Ayesha Alvero | |||
| P2860 | cites work | KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells | Q21245466 |
| Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties | Q21562142 | ||
| Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers | Q21562662 | ||
| A family of human receptors structurally related to Drosophila Toll | Q24321888 | ||
| Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells | Q24618984 | ||
| Identification and characterization of ovarian cancer-initiating cells from primary human tumors | Q24644329 | ||
| Twist-1 regulates the miR-199a/214 cluster during development | Q24652478 | ||
| A twist for survival and cancer progression | Q24652500 | ||
| Chemoresistance in human ovarian cancer: the role of apoptotic regulators | Q24791433 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1 | Q28211306 | ||
| Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells | Q28264780 | ||
| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
| Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance | Q28307294 | ||
| A twist code determines the onset of osteoblast differentiation | Q28510533 | ||
| Nuclear factor-kappaB in cancer development and progression | Q29547879 | ||
| Stem cell origin of cancer and differentiation therapy | Q33203952 | ||
| MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer. | Q33302912 | ||
| Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival | Q33312949 | ||
| Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant? | Q33917956 | ||
| TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. | Q33927452 | ||
| Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. | Q34149945 | ||
| Current diagnosis and treatment modalities for ovarian cancer | Q34483859 | ||
| Toll-like receptors and their role in the trophoblast | Q36182212 | ||
| The anti-death machinery in IKK/NF-kappaB signaling | Q36354713 | ||
| Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors | Q36384609 | ||
| Mammary stem and progenitor cells: tumour precursors? | Q36477023 | ||
| Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function | Q36662693 | ||
| Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway | Q36705250 | ||
| Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance | Q36769448 | ||
| TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity | Q36811126 | ||
| Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells | Q37051030 | ||
| Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay | Q37087058 | ||
| A twist of insight - the role of Twist-family bHLH factors in development | Q37332873 | ||
| Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity. | Q39735898 | ||
| TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer | Q40296306 | ||
| Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target | Q40409031 | ||
| Divergent trophoblast responses to bacterial products mediated by TLRs | Q40512735 | ||
| Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule | Q40820381 | ||
| Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation | Q44240311 | ||
| Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages | Q44521272 | ||
| Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis | Q47665950 | ||
| Trends in the leading causes of death in the United States, 1970-2002. | Q47858987 | ||
| TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. | Q50737248 | ||
| twist: a myogenic switch in Drosophila. | Q52201086 | ||
| Adult stem cel diferentiation and trafficking and their implications in disease. | Q53276393 | ||
| Expression of twist and wnt in human breast cancer. | Q53360264 | ||
| Stem Cells and Cancer: Two Faces of Eve | Q59243883 | ||
| The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense | Q73049177 | ||
| Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer | Q81656206 | ||
| Cancer occurrence | Q83093238 | ||
| P433 | issue | 8 | |
| P921 | main subject | ovarian cancer | Q172341 |
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 708-713 | |
| P577 | publication date | 2011-04-15 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | Ovarian cancer stem cells and inflammation | |
| P478 | volume | 11 |
| Q34372200 | A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population |
| Q36140826 | Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer. |
| Q38943910 | Biological characteristics of CD133(+) cancer stem cells derived from human laryngeal carcinoma cell line. |
| Q50500650 | Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures. |
| Q45612220 | Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma |
| Q36989636 | Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential |
| Q36999077 | Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype |
| Q26849477 | Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach |
| Q36791997 | High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer |
| Q36563742 | Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer |
| Q33890763 | Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer |
| Q38813155 | MicroRNA and gynecologic cancers |
| Q37687793 | NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells |
| Q35837949 | Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways |
| Q35195618 | Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer |
| Q55084775 | Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer. |
| Q36654413 | TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence |
| Q36174805 | Targeted cancer therapy--are the days of systemic chemotherapy numbered? |
| Q37272169 | Techniques for following labeled cells in vivo: use of X/Y FISH, techniques to optimize fluorescent detection, and beta-galactosidase detection |
| Q39112597 | The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer |
| Q36919484 | The duplicitous origin of ovarian cancer |
| Q34285178 | The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells |
| Q26786826 | The role of reproductive hormones in epithelial ovarian carcinogenesis |
| Q55461517 | The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. |
| Q33718878 | Tumor-associated macrophages contribute to tumor progression in ovarian cancer. |
| Q35844366 | VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients |
Search more.